ALRN all the way down to ONCX are all “clinical stage” bio pharma companies. So none of them have drugs out on the market. Many have multiple drugs in trials. Oncolix is looking to add more to their pipeline. More drugs in trials and Phase 2 for Oncolix could be huge. Thanks for compiling that info Arby...great post.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.